Literature DB >> 16896973

[Recurring, severe upper abdominal pain in a 45 year old patient].

E Biecker1, H-P Fischer, G Lutterbey, U Pütz, T Sauerbruch, F Lammert.   

Abstract

A 45-year-old patient presented with a history of recurrent abdominal pain of unknown origin. The CT scan of the abdomen demonstrated a thickened mesenteric root and a segmental ileus of the jejunum. Laparotomy revealed a neuroendocrine tumour of the small bowel. Such tumours are rare causes of recurrent abdominal pain. Especially when the CT scan of the abdomen reveals mesenteric abnormalities (desmoplastic reaction) and/or a segmental ileus, a neuroendocrine tumour of the small bowel should be considered. The therapy of choice is resection of the tumour followed by systemic therapy including somatostain analogues and chemotherapy in the case of a hormone secreting tumour or metastases.

Entities:  

Mesh:

Year:  2006        PMID: 16896973     DOI: 10.1007/s00108-006-1692-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

1.  Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.

Authors:  I Norheim; K Oberg; E Theodorsson-Norheim; P G Lindgren; G Lundqvist; A Magnusson; L Wide; E Wilander
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

Review 2.  Gastrointestinal carcinoid tumors: current management strategies.

Authors:  M A Memon; H Nelson
Journal:  Dis Colon Rectum       Date:  1997-09       Impact factor: 4.585

3.  Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Authors:  R Arnold; M E Trautmann; W Creutzfeldt; R Benning; M Benning; C Neuhaus; R Jürgensen; K Stein; H Schäfer; C Bruns; H J Dennler
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

4.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Authors:  Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2003 Jan-Feb       Impact factor: 3.488

5.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

6.  CT evaluation of small bowel neoplasms: spectrum of disease.

Authors:  J A Buckley; E K Fishman
Journal:  Radiographics       Date:  1998 Mar-Apr       Impact factor: 5.333

Review 7.  Somatostatin receptor imaging.

Authors:  Dik J Kwekkeboom; Eric P Krenning
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

8.  One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.

Authors:  F A Greco; J D Hainsworth
Journal:  Semin Oncol       Date:  1997-12       Impact factor: 4.929

9.  Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

Authors:  Siegbert Faiss; Ulrich-Frank Pape; Michael Böhmig; Yvonne Dörffel; Ulrich Mansmann; Werner Golder; Ernst Otto Riecken; Bertram Wiedenmann
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

10.  Computed tomography of abdominal carcinoid tumor.

Authors:  B M Cockey; E K Fishman; B Jones; S S Siegelman
Journal:  J Comput Assist Tomogr       Date:  1985 Jan-Feb       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.